Price movement over the last 24 hours
Align Technology, Inc. vs Cytokinetics Inc — how do they compare? Align Technology, Inc. trades at $175 (market cap $13.27B), while Cytokinetics Inc trades at $84.75 (market cap $11.62B). The key difference: Align Technology, Inc. and Cytokinetics Inc are close in size by market cap, and Cytokinetics Inc is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | CYTK | |
|---|---|---|
Market Cap | $13.27B | $11.62B |
Sector | Health | Technology |
52-Week High | $207.19 | $87.26 |
52-Week Low | $124.88 | $33.23 |
Enterprise Value | $12.32B | $12.09B |
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →